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Our Goals for Today
Help you understand this complex process 
so that you can:
 Anticipate how you and others make the 
decision to get vaccinated
 Have conversations with others about 
COVID-19 vaccines
Hesitancy and Excitement
Reasons people cite for being hesitant (Hamel 
et al., Jan. 2021; Funk & Tyson, Dec. 2020)
 Side effects
 Prevent me from getting COVID?
 Newness
 Distrust of medical system
Hesitancy and Excitement
Hesitancy more common among:
 Blacks
 Republicans
 ...but willingness is rising
Hesitancy and Excitement
Reasons people are excited to get vaccinated 
(Funk & Tyson, Dec. 2020)
 Safety and effectiveness
 ~50 million doses given in U.S.
 More than 10% of population
How do these vaccines work?
How do these vaccines work?
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Known Side Effects
COVID-19












 Serious allergic reaction 
(11 cases in one million 
doses, or incidence of 
0.0011%)
What about the other 
vaccines?
 More vaccines coming down the pipeline
 AstraZeneca/Oxford (76%)
 Johnson & Johnson/Janssen (~85%)
 More
 These are *great* vaccines!
 Will reduce severe disease
Vaccine Distribution
What the @$%& happened?
Goals of U.S. PH Institutions
 Prevent epidemics and the spread of 
disease
 Protect against environmental hazards
 Prevent injuries
 Promote and encourage health 
behaviors
 Respond to disasters, assist in recovery












Other Vaccine Roll Out 
Challenges
 Supply shortages
 Lack of federal support/guidance/$$$$
 Type of vaccine requires extreme cold so 
hospitals first line distributors
 No universal healthcare infrastructure
 Those not aligned with systems cannot 
navigate the technology
WE WERE NOT READY
Why mask and distance after 
vaccination?







What should I say?
First, ask questions… (people’s reasons for 
vaccine hesitancy differ)
 Who do you trust for information? 
 Find recommendations and info from someone 
person trusts, identifies with, and has expertise
 False information often sensationalizes and lacks 
data; Accurate information often presents a lot of 
data
What should I say?
First, ask questions… (people’s reasons for 
vaccine hesitancy differ)
 What information would help you make your 
decision?
 Safety and efficacy: Data from thousands and 
thousands of people has found the vaccines to be 
safe and effective. 50 million doses given now.
 Research and development process: Didn’t cut 
corners. Cut the red tape.
 For those who don't believe COVID to be severe, 
vaccine one tool to lower rates, speed reopening
What should I say?
First, ask questions… (people’s reasons for 
vaccine hesitancy differ)
 What are the benefits/pros of getting 
vaccinated for you?
 Less likely to get sick
 Peace of mind
 Travel, spend time with others (with less risk)
What should I say?
Second, help people get an appointment…
 When and where can they get vaccinated?
 How can they make an appointment?
 Help them register for an appointment and 
help them get there (transportation)
Do you know someone who is 
hesitant?
 Let's brainstorm!
 Picture someone in your life you want to 
talk to about COVID-19 vaccines
 Consider what you might ask and what 
you might say
 Discuss with your group
Resources














 Pennsylvania Department of 
Health https://www.health.pa.gov/topics/disease/
coronavirus/Vaccine/Pages/Vaccine.aspx





What is Herd 
Immunity?
When most of a population is 
immune to an infectious 
disease, this provides indirect 
protection to those who are 
not immune to the disease
What are these new COVID 
variants?
 Viruses generate mutations as long as 
they are replicating
 Concern about variants identified in the 
UK, South Africa, Brazil and USA
 Mutations in spike make them able to 
dodge immune system to an extent
 Current vaccines are still effective, but 
somewhat reduced (from super excellent 
to excellent)
 New variants require increased masking, 
distancing, and protection
Why mask and distance after 
vaccination?
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